Patrick Mayeux
Impact in
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Erythropoietin and Anemia Treatment
- Genetics top 0.5%
- Hemoglobinopathies and Related Disorders
Papers in
- Hematology 89
- Erythropoietin and Anemia Treatment 30
- Acute Myeloid Leukemia Research 29
- Genetics 46
- Hemoglobinopathies and Related Disorders 25
- Chronic Lymphocytic Leukemia Research 12
- Co-authors
- Catherine Lacombe (47 shared papers)Didier Bouscary (36 shared papers)Sylvie Gisselbrecht (33 shared papers)Stany Chrétien (28 shared papers)Jérôme Tamburini (31 shared papers)Nicole Casadevall (17 shared papers)Nicolas Chapuis (26 shared papers)Odile Muller (15 shared papers)
- Journals
- Blood (57 papers)Journal of Biological Chemistry (15 papers)Haematologica (12 papers)Leukemia (10 papers)Oncogene (5 papers)
- Partner nations
- FranceUnited StatesMorocco
In The Last Decade
Patrick Mayeux
182 papers receiving 10.0k citations
Patrick Mayeux's Hit Papers
Peers
Comparison fields: 5 of 129
- Hematology 3.7k
- Genetics 1.6k
- Immunology 1.9k
- Cancer Research 1.2k
- Oncology 2.1k
Countries citing papers authored by Patrick Mayeux
This map shows the geographic impact of Patrick Mayeux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Mayeux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Mayeux more than expected).
Fields of papers citing papers by Patrick Mayeux
This network shows the impact of papers produced by Patrick Mayeux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Mayeux. The network helps show where Patrick Mayeux may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Mayeux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 184 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin Hit paper breakdown → | 2002 | 967 |
| 2 | 2015 | 322 | |
| 3 | 2002 | 266 | |
| 4 | 2009 | 257 | |
| 5 | 2013 | 251 | |
| 6 | 2007 | 223 | |
| 7 | 2016 | 192 | |
| 8 | 1996 | 190 | |
| 9 | 2012 | 176 | |
| 10 | 1996 | 171 | |
| 11 | 2010 | 170 | |
| 12 | Biology of erythropoietin. | 1998 | 167 |
| 13 | 1998 | 166 | |
| 14 | 2009 | 164 | |
| 15 | 2008 | 157 | |
| 16 | 2003 | 152 | |
| 17 | 2021 | 151 | |
| 18 | 1994 | 147 | |
| 19 | 2004 | 145 | |
| 20 | 2011 | 144 |
About Patrick Mayeux
Patrick Mayeux is a scholar working on Hematology, Genetics, Physiology, Molecular Biology and Immunology, having authored 184 papers that have together received 10.3k indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (62 papers), Erythropoietin and Anemia Treatment (30 papers), Acute Myeloid Leukemia Research (29 papers), Hemoglobinopathies and Related Disorders (25 papers), PI3K/AKT/mTOR signaling in cancer (23 papers), Cytokine Signaling Pathways and Interactions (16 papers), PARP inhibition in cancer therapy (15 papers) and Chronic Lymphocytic Leukemia Research (12 papers). The work is most often cited by research in Hematology (3.7k citations), Genetics (1.6k citations), Immunology (1.9k citations), Cancer Research (1.2k citations) and Oncology (2.1k citations). Patrick Mayeux has collaborated with scholars based in France, United States and Morocco. Frequent co-authors include Catherine Lacombe, Didier Bouscary, Sylvie Gisselbrecht, Stany Chrétien, Jérôme Tamburini, Nicole Casadevall, Nicolas Chapuis, Odile Muller, Frédèrique Verdier and François Dreyfus. Their work appears in journals such as Blood, Journal of Biological Chemistry, Haematologica, Leukemia and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.